Literature DB >> 2763228

Exercise responses in patients treated for pulmonary tuberculosis by thoracoplasty.

M S Phillips1, W J Kinnear, D Shaw, J M Shneerson.   

Abstract

Twenty eight subjects (mean age 64 years) who had been treated for tuberculosis by thoracoplasty in the past performed an increasing work rate exercise test, from which maximum oxygen consumption (VO2max), ventilation and heart rate were measured. VO2max was significantly lower than predicted, being 0.75 l/min in 17 subjects, 1.0 l/min in 10, and 1.5 l/min in one. Only one subject achieved a heart rate of 85% of the predicted maximum. The ratio of heart rate to oxygen consumption (HR/VO2) and heart rate at standard interpolated submaximal levels of oxygen uptake at 0.75 l/min (heart rate 0.75) and 1.0 l/min (heart rate 1.0) were normal. VO2max correlated with ventilation at maximal exercise (VE max) (r = 0.87) and FEV1 (r = 0.47). It did not correlate with resting arterial oxygen or carbon dioxide tensions, FEV1, maximum inspiratory pressure, angle of scoliosis, or number of ribs resected. The relation between ventilation and oxygen consumption (VE/VO2) and VE at the submaximal levels of oxygen consumption of 0.75 l/min (VE 0.75) and 1.0 l/min (VE 1.0) were normal. In 10 subjects a plateau of breathing frequency (fmax) was reached, after which the increase in ventilation was achieved by a further increase in tidal volume (VT). These subjects showed significantly lower values for the forced expiratory ratio, VO2max, and VEmax than those with a normal relation between tidal volume and breathing frequency. VEmax was correlated with FEV1 (r = 0.61), FVC (r = 0.46), maximum VT (r = 0.55), change in VT (r = 0.52), fmax (r = 0.56), and change in breathing frequency (r = 0.72). These results indicate that exercise in patients treated for tuberculosis by thoracoplasty is limited by ventilatory capacity and that this is due to a reduction in both dynamic lung volumes and respiratory frequency.

Entities:  

Mesh:

Year:  1989        PMID: 2763228      PMCID: PMC461789          DOI: 10.1136/thx.44.4.268

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Tuberculosis--a cause of emphysema.

Authors:  J F LANCASTER; J F TOMASHEFSKI
Journal:  Am Rev Respir Dis       Date:  1963-03

2.  Studies on respiratory mechanics and the work of breathing in pulmonary fibrosis.

Authors:  J R WEST; J K ALEXANDER
Journal:  Am J Med       Date:  1959-10       Impact factor: 4.965

3.  Twelve-minute walking test for assessing disability in chronic bronchitis.

Authors:  C R McGavin; S P Gupta; G J McHardy
Journal:  Br Med J       Date:  1976-04-03

4.  Left ventricular function in chronic obstructive lung disease.

Authors:  G L Baum; A Schwartz; R Llamas; C Castillo
Journal:  N Engl J Med       Date:  1971-08-12       Impact factor: 91.245

5.  Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease.

Authors:  R A Bruce; F Kusumi; D Hosmer
Journal:  Am Heart J       Date:  1973-04       Impact factor: 4.749

6.  Scoliosis after thoracoplasty.

Authors:  R D Loynes
Journal:  J Bone Joint Surg Br       Date:  1972-08

7.  Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease.

Authors:  W A Potter; S Olafsson; R E Hyatt
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

8.  The cardiorespiratory response to exercise in thoracic scoliosis.

Authors:  J M Shneerson
Journal:  Thorax       Date:  1978-08       Impact factor: 9.139

9.  Assessment of respiratory function in patients with chronic obstructive airways disease.

Authors:  I P Mungall; R Hainsworth
Journal:  Thorax       Date:  1979-04       Impact factor: 9.139

10.  An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis.

Authors:  S G Spiro; H L Hahn; R H Edwards; N B Pride
Journal:  Thorax       Date:  1975-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.